Isaac Israel
Interim Chief Executive Officer & DirectorMr. Isaac Israel is Independent Director of Nasus Pharma Ltd. from August 13, 2025. Mr. Israel has been a Director of Purple Biotech Ltd. (formerly known as Kitov Pharma Ltd). (formerly, Kitov Pharmaceuticals Holdings LTD.) since October 2012 and also serves as Interim Chief Executive Officer Since October 5, 2026. He served as Acting Chief Executive Officer of Purple Biotech Ltd. since March 2023 until August 2023. He had been the Chief Executive Officer of Purple Biotech Ltd. (formerly known as Kitov Pharma Ltd). (formerly, Kitov Pharmaceuticals Holdings LTD.) since October 2012 until July 10, 2022. Prior to joining Kitov, Mr. Israel served as Vice President of Business Development at Capital Point Ltd. He was founding Chief Executive Officer of BeeContact Ltd. (formerly TASE: BCNT), from 2001 to 2007. Mr. Israel founded and managed BeeContact Communications and Uneri Capital. Mr. Israel was the founding Chief Executive Officer of Uneri Capital from 2008 to 2011. Mr. Israel is a healthcare entrepreneur with a strong business development, capital markets and financial background. He served as founding Chief Executive Officer of Unari Capital Ltd., a consulting firm in the capital markets field specializing in the healthcare sector. Mr. Israel also serves as the Chairman of the Board of NextGen BioMed. He serves as a Director of RDD Pharma, Ltd.
Positions
- Company NamePurple Biotech LtdStock CodePPBTPositionInterim Chief Executive Officer & Director
